ESRP1 was found to suppress tumorigenic potential in vivo [15], and the levels of ESRP1 mRNA measured using real-time quantitative reverse transcription-polymerase chain reaction correlate with favorable outcomes [48], suggesting that ESRP1 plays a tumor-suppressive role in colorectal cancer. Here, ESRP1 is linked to colorectal cancer.